耐药与敏感肺结核病人疾病经济负担对照研究

The Comparative Analysis of Disease Fianacial Burden of Drug-resistant Tuberculosis and Drug-sensitive Tuberculosis

目的 研究耐药与敏感肺结核病人的疾病经济负担。方法 调查了 15个“WHO结核病耐药监测”县(市 )耐药与敏感病人 2 0 7例 ,利用经济学评价方法 ,探讨其疾病经济负担。结果 例均家庭疾病经济负担 :初治耐药组为 3 0 61 5元、敏感组为 2 10 3 7元 ;复治耐药组为 8414 0元、敏感组为 6798 1元。例均社会疾病经济总负担 ,耐药患者为 14 65 5 3 0元 ,敏感患者为 5 740 68元。耐药是敏感的 2 6倍。结论 耐药肺结核病患者无论是家庭疾病经济负担 ,还是社会疾病经济负担都要比药物敏感肺结核患者要高。

Objective To study disease financial burden of drug-resistant and drug-sensitive TB in Zhejiang Method 15 counties were randomly selected from 30 surveillance counties of“a global drug-resistance surveillance of TB project of WHO” 207 cases of drug-resistance and drug-sensitive TB were intaken continuously in each counties The method of economic evaluation was used to explore the disease financial burden carried by the patients'families and society Results The average family disease financial burden was as follows:3061 5 yuan for drug-resistant initial treatment TB,2103 7 yuan for drug-sensitive initial treatment TB,8414 0 yuan for drug-resistant re-treatment TB and 6798 1 yuan for drug-sensitive re-treatment TB The average social disease financial burden was as follows:14655 30 yuan for drug-resistant TB,5740 68 yuan for drug-sensitive TB Conclusion Both the family disease financial burden and social disease financial burden of drug-resistant TB are obviously higher than that of drug-sensitive TB